BSE filing, NSE: DABUR. Summary written from the filing by ALFA Finder's alert engine.
Dabur India Ltd: key numbers
- Share price
- ₹360.00
- Market cap
- ₹63,862 Cr
- Revenue (annual)
- ₹13,193 Cr
- Net profit (annual)
- ₹1,895 Cr
- P/E (TTM)
- 32.4×Sector 38.6×
- Promoter holding
- 66.25%+0.01% QoQ
- FII holding
- 9.60%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dabur India Ltd
All →Dabur India Other Announcement
Dabur India Ltd filed its quarterly shareholding pattern as of September 30, 2026, noting changes in promoter entities due to mergers and corporate actions.
Dabur India Debt & Borrowing: ₹250 Cr
Dabur India submitted a periodic disclosure for its Rs. 250 Crore Unsecured Non-Convertible Debentures, confirming the outstanding status as of September 2026.
- Value
- ₹250.0 Cr
Dabur India Business Update
Dabur issued a pre-results Q2 FY27 demand update expecting double-digit consolidated revenue and PAT growth. Segment-level qualitative growth bands are provided without specific rupee figures.
Dabur India Acquisition
Dabur India Limited received NCLT approval for the merger of Sesa Care Private Limited into the company. This integration strengthens Dabur's Ayurvedic hair care portfolio following an initial 51% CRPS acquisition.
Dabur India Board Meeting Date
Dabur India announced a board meeting on 04 Nov 2026 to consider Q1 FY27 unaudited results and interim dividend. No financial figures are disclosed in this advance notice.
Dabur India Other Announcement
Dabur India has submitted updated contact details for its Key Managerial Personnel (KMP) authorized for determining event materiality under Regulation 30(5) of SEBI LODR.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.